
The overall goal of the Lee lab’s research program is to improve the survivorship of cancer patients by minimizing acute and long-term side effects of radiation therapy. We are also investigating novel medical countermeasures against acute radiation syndrome in the scenarios of nuclear terrorism.
Education and Training
- Postdoctoral Associate, Radiation Oncology/Kirsch Laboratory, Duke University School of Medicine, 2012 - 2017
- Ph.D., Duke University, 2012
Selected Grants
- Inhibition of CaMKK2 sensitizes rectal cancers to radiation therapy
- Minimizing the risk of therapy-related myeloid neoplasms by inhibiting genotoxic stress-induced expansion of leukemia-initiating cells
- Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus
- Mitigating the gastrointestinal acute radiation syndrome by blocking calcium/calmodulin-dependent protein kinase kinase 2
- Treatment of gastrointestinal acute radiation syndrome with activation of peroxisome proliferator-activated receptor delta
- Development of CaMKK2 inhibitor drug for acute radiation syndrome
- Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus